Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Breast Cancer

Free Subscription Articles published in Oncogene Retrieve available abstracts of 75 articles: HTML format Text format

Single Articles

March 2010
1. MILLOUR J , Constantinidou D, Stavropoulou AV, Wilson MS, et al
   FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CALDWELL SA , Jackson SR, Shahriari KS, Lynch TP, et al
   Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
3. ZHANG W , Zeng X, Briggs KJ, Beaty R, et al
   A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. LAM S , Lodder K, Teunisse AF, Rabelink MJ, et al
   Role of Mdm4 in drug sensitivity of breast cancer cells.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. SEHGAL PB
   Interleukin-6 induces increased motility, cell-cell and cell-substrate dyshesion and epithelial-to-mesenchymal transformation in breast cancer cells.
   Oncogene. 2010.
   PubMed     Text format     Related articles   
   
   
   January 2010
6. FOUGERE M , Gaudineau B, Barbier J, Guaddachi F, et al
   NFAT3 transcription factor inhibits breast cancer cell motility by targeting the Lipocalin 2 gene.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. WEST NR , Watson PH
   S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.
   Oncogene. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
8. PETERSEN M , Pardali E, van der Horst G, Cheung H, et al
   Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis.
   Oncogene. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
9. POWERS GL , Ellison-Zelski SJ, Casa AJ, Lee AV, et al
   Proteasome inhibition represses ERalpha gene expression in ER+ cells: a new link between proteasome activity and estrogen signaling in breast cancer.
   Oncogene. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. KULKARNI S , Reddy KB, Esteva FJ, Moore HC, et al
    Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. ROIDL A , Foo P, Wong W, Mann C, et al
    The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. LIN Z , Yin P, Reierstad S, O'Halloran M, et al
    Adenosine A1 receptor, a target and regulator of estrogen receptoralpha action, mediates the proliferative effects of estradiol in breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. MADEO A , Vinciguerra M, Lappano R, Galgani M, et al
    c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. KHODAREV N , Ahmad R, Rajabi H, Pitroda S, et al
    Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. RIBEIRO AS , Albergaria A, Sousa B, Correia AL, et al
    Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. BOCANEGRA M , Bergamaschi A, Kim YH, Miller MA, et al
    Focal amplification and oncogene dependency of GAB2 in breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. ZHANG J , Li Y, Liu Q, Lu W, et al
    Wnt signaling activation and mammary gland hyperplasia in MMTV-LRP6 transgenic mice: implication for breast cancer tumorigenesis.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
18. THOENNISSEN NH , O'Kelly J, Lu D, Iwanski GB, et al
    Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. HAO L , Rizzo P, Osipo C, Pannuti A, et al
    Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. MIRA A , Isella C, Renzulli T, Cantarella D, et al
    The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. WOLF I , Laitman Y, Rubinek T, Abramovitz L, et al
    Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. LI Y , Ye X, Tan C, Hongo JA, et al
    Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis.
    Oncogene. 2009;28:3442-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
23. LIU G , Bollig-Fischer A, Kreike B, van de Vijver MJ, et al
    Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. MONTANO X
    Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. BRADY SN , Maggi LB Jr, Winkeler CL, Toso EA, et al
    Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
    Oncogene. 2009;28:3209-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. PESCHIAROLI A , Scialpi F, Bernassola F, Pagano M, et al
    The F-box protein FBXO45 promotes the proteasome-dependent degradation of p73.
    Oncogene. 2009;28:3157-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. MULL BB , Cox J, Bui T, Keyomarsi K, et al
    Post-translational modification and stability of low molecular weight cyclin E.
    Oncogene. 2009;28:3167-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
28. WORTHAM NC , Ahamed E, Nicol SM, Thomas RS, et al
    The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. LI XF , Yan PJ, Shao ZM
    Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. CONFALONIERI S , Quarto M, Goisis G, Nuciforo P, et al
    Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor.
    Oncogene. 2009;28:2959-68.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. LEIVONEN SK , Makela R, Ostling P, Kohonen P, et al
    Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. ZHAO YH , Zhou M, Liu H, Ding Y, et al
    Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. MONTANEZ-WISCOVICH ME , Seachrist DD, Landis MD, Visvader J, et al
    LMO4 is an essential mediator of ErbB2/HER2/Neu-induced breast cancer cell cycle progression.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
34. PRATT MA , Tibbo E, Robertson SJ, Jansson D, et al
    The canonical NF-kappaB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population.
    Oncogene. 2009;28:2710-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. LI J , Yang L, Song L, Xiong H, et al
    Astrocyte elevated gene-1 is a proliferation promoter in breast cancer via suppressing transcriptional factor FOXO1.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. SULLIVAN NJ , Sasser AK, Axel AE, Vesuna F, et al
    Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
37. LI Y , Zhou Z, Alimandi M, Chen C, et al
    WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. ASTANEHE A , Finkbeiner MR, Hojabrpour P, To K, et al
    The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.
    Oncogene. 2009;28:2406-18.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. ZHOU W , Tu Y, Simpson PJ, Kuhajda FP, et al
    Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. SU S , Li Y, Luo Y, Sheng Y, et al
    Proteinase-activated receptor 2 expression in breast cancer and its role in breast cancer cell migration.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. HOENERHOFF MJ , Chu I, Barkan D, Liu ZY, et al
    BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. LARIVE RM , Urbach S, Poncet J, Jouin P, et al
    Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion.
    Oncogene. 2009;28:2337-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. ROOVERS K , Wagner S, Storbeck CJ, O'Reilly P, et al
    The Ste20-like kinase SLK is required for ErbB2-driven breast cancer cell motility.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. RADPOUR R , Kohler C, Haghighi MM, Fan AX, et al
    Methylation profiles of 22 candidate genes in breast cancer using high-throughput MALDI-TOF mass array.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. AKAOGI K , Nakajima Y, Ito I, Kawasaki S, et al
    KLF4 suppresses estrogen-dependent breast cancer growth by inhibiting the transcriptional activity of ERalpha.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. DYDENSBORG AB , Rose AA, Wilson BJ, Grote D, et al
    GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. TALIAFERRO-SMITH L , Nagalingam A, Zhong D, Zhou W, et al
    LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. WALTER M , Liang S, Ghosh S, Hornsby PJ, et al
    Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
49. JONES RA , Campbell CI, Wood GA, Petrik JJ, et al
    Reversibility and recurrence of IGF-IR-induced mammary tumors.
    Oncogene. 2009;28:2152-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. LAITEM C , Leprivier G, Choul-Li S, Begue A, et al
    Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51.
    Oncogene. 2009;28:2087-99.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. KANG J , Perry JK, Pandey V, Fielder GC, et al
    Artemin is oncogenic for human mammary carcinoma cells.
    Oncogene. 2009;28:2034-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. WU D , Asiedu M, Wei Q
    Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. KATO M , Paranjape T, Ullrich R, Nallur S, et al
    The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
54. KWEK SS , Roy R, Zhou H, Climent J, et al
    Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis.
    Oncogene. 2009;28:1892-903.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. FOX BP , Kandpal RP
    EphB6 receptor significantly alters invasiveness and other phenotypic characteristics of human breast carcinoma cells.
    Oncogene. 2009;28:1706-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
56. LAGADEC C , Meignan S, Adriaenssens E, Foveau B, et al
    TrkA overexpression enhances growth and metastasis of breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. JANG M , Park BC, Kang S, Chi SW, et al
    Far upstream element-binding protein-1, a novel caspase substrate, acts as a cross-talker between apoptosis and the c-myc oncogene.
    Oncogene. 2009;28:1529-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. NIKKILA J , Coleman KA, Morrissey D, Pylkas K, et al
    Familial breast cancer screening reveals an alteration in the RAP80 UIM domain that impairs DNA damage response function.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. FINKBEINER MR , Astanehe A, To K, Fotovati A, et al
    Profiling YB-1 target genes uncovers a new mechanism for MET receptor regulation in normal and malignant human mammary cells.
    Oncogene. 2009;28:1421-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. MILLAR EK , Dean JL, McNeil CM, O'Toole SA, et al
    Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. ZHOU Q , Geahlen RL
    The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.
    Oncogene. 2009;28:1348-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
62. GONZALEZ ME , Li X, Toy K, DuPrie M, et al
    Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1.
    Oncogene. 2009;28:843-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. LEE JY , Kang MB, Jang SH, Qian T, et al
    Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition.
    Oncogene. 2009;28:824-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SCALTRITI M , Verma C, Guzman M, Jimenez J, et al
    Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicity.
    Oncogene. 2009;28:803-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. VEUGER SJ , Hunter JE, Durkacz BW
    Ionizing radiation-induced NF-kappaB activation requires PARP-1 function to confer radioresistance.
    Oncogene. 2009;28:832-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
66. GONZALEZ L , Zambrano A, Lazaro-Trueba I, Lopez E, et al
    Activation of the unliganded estrogen receptor by prolactin in breast cancer cells.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. PICKL M , Ries CH
    Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab.
    Oncogene. 2009;28:461-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. ZHANG Y , Zhang M, Dong H, Yong S, et al
    Deacetylation of cortactin by SIRT1 promotes cell migration.
    Oncogene. 2009;28:445-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. HOLLMEN M , Maatta JA, Bald L, Sliwkowski MX, et al
    Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. WOO HH , Zhou Y, Yi X, David CL, et al
    Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer.
    Oncogene. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. SMITH JR , Clarke PA, de Billy E, Workman P, et al
    Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors.
    Oncogene. 2009;28:157-69.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. MOLLER A , House CM, Wong CS, Scanlon DB, et al
    Inhibition of Siah ubiquitin ligase function.
    Oncogene. 2009;28:289-96.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
73. CAO Q , Yu J, Dhanasekaran SM, Kim JH, et al
    Repression of E-cadherin by the polycomb group protein EZH2 in cancer.
    Oncogene. 2008;27:7274-84.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
74. CRANE CA , Panner A, Murray JC, Wilson SP, et al
    PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer.
    Oncogene. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
75. RODRIGUEZ-GONZALEZ A , Cyrus K, Salcius M, Kim K, et al
    Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer.
    Oncogene. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: